2026 Q2 Portfolio Activity
In 2026 Q2, BRAIDWELL LP maintained a portfolio of 112 distinct positions. The most significant new addition was HUMANA INC, now representing 1.68% of the total fund value. They heavily accumulated shares in ALPHATEC HLDGS INC, increasing the position by 2972.0%. Conversely, BRAIDWELL LP completely exited their position in GUARDANT HEALTH INC.
Position History
hover any row below to update
Loading…
Total Positions
112
Quarter
2026 Q2
Top Holding
CAI (5.4%)
Top 10 Concentration
31.6%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-50 of 112
BRAIDWELL LP Full Holdings List — 2026 Q2
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
CAI
CARIS LIFE SCIE...
|
Healthcare | 5.44% | 4.78% |
#1
Prev: #1
|
4.7 |
—
|
246,585 | 3.1% |
P
S
|
8,256,032 | $147,122,490 |
$26.26
-17.0%
|
2025 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | ||
|
HNGE
HINGE HEALTH IN...
|
Healthcare | 4.08% | 1.87% |
#2
15
Prev: #17
|
3.6 |
—
|
-124,996 | -8.6% |
P
S
|
1,330,127 | $110,400,541 | 2025 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
GKOS
GLAUKOS CORP
|
Healthcare | 3.06% | 2.74% |
#3
3
Prev: #6
|
2.2 |
—
|
-171,578 | -22.5% |
P
S
|
591,927 | $82,727,718 | 2022 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
EWTX
EDGEWISE THERAP...
|
Healthcare | 3.00% | 2.47% |
#4
6
Prev: #10
|
2.2 |
—
|
-350,618 | -14.9% |
P
S
|
1,996,965 | $81,136,688 | 2024 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
SYRE
SPYRE THERAPEUT...
|
Healthcare | 2.89% | 1.57% |
#5
16
Prev: #21
|
2.2 |
—
|
-53,356 | -5.7% |
P
S
|
879,467 | $78,079,080 | 2023 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
IRTC
IRHYTHM HOLDING...
|
Healthcare | 2.88% | 2.40% |
#6
5
Prev: #11
|
3.2 |
—
|
44,070 | 7.2% |
P
S
|
654,262 | $77,824,465 | 2022 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
NEO
NEOGENOMICS INC
|
Healthcare | 2.65% | 1.39% |
#7
21
Prev: #28
|
1.6 |
—
|
-699,200 | -12.4% |
P
S
|
4,918,202 | $71,756,567 | 2025 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
KOD
KODIAK SCIENCES...
|
Healthcare | 2.58% | 2.31% |
#8
5
Prev: #13
|
1.5 |
—
|
-31,347 | -1.7% |
P
S
|
1,787,318 | $69,633,909 | 2022 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
XENE
XENON PHARMACEU...
|
Healthcare | 2.53% | 2.60% |
#9
1
Prev: #8
|
1.5 |
—
|
-207,000 | -15.5% |
P
S
|
1,131,452 | $68,294,443 | 2022 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
N/A
ALPHATEC HLDGS ...
|
|
Bond/Debt | 2.45% | 2.11% |
#10
5
Prev: #15
|
3.0 |
—
|
7,500,000 | 12.2% |
P
S
|
69,121,000 | $66,183,358 | — | 13F Filing | 2026-06-30 | 2026-08-14 | ||
|
GLUE
MONTE ROSA THER...
|
Healthcare | 2.19% | 1.76% |
#11
8
Prev: #19
|
0.9 |
—
|
-755,012 | -23.5% |
P
S
|
2,451,562 | $59,327,800 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
DNTH
DIANTHUS THERAP...
|
Healthcare | 2.14% | 2.52% |
#12
3
Prev: #9
|
0.9 |
—
|
-304,802 | -33.9% |
P
S
|
594,562 | $57,957,904 | 2024 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
NBIX
NEUROCRINE BIOS...
|
Healthcare | 2.10% | 2.87% |
#13
8
Prev: #5
|
0.8 |
—
|
-315,950 | -48.4% |
P
S
|
336,171 | $56,656,579 | 2023 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ATEC
ALPHATEC HLDGS ...
|
Healthcare | 2.09% | 0.79% |
#14
37
Prev: #51
|
3.8 |
—
|
4,358,714 | 200.6% |
P
S
|
6,531,439 | $56,496,947 | 2023 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
N/A
GENERATE BIOMED...
|
|
Unknown | 2.05% | 1.50% |
#15
9
Prev: #24
|
1.3 |
—
|
-309,155 | -8.6% |
P
S
|
3,283,844 | $55,398,448 | — | 13F Filing | 2026-06-30 | 2026-08-14 | ||
|
MRVI
MARAVAI LIFESCI...
|
Healthcare | 2.01% | 0.97% |
#16
22
Prev: #38
|
1.3 |
—
|
-1,537,243 | -15.0% |
P
S
|
8,702,921 | $54,306,227 | 2023 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
KRYS
KRYSTAL BIOTECH...
|
Healthcare | 1.77% | 1.57% |
#17
3
Prev: #20
|
0.7 |
—
|
-53,450 | -29.3% |
P
S
|
128,975 | $47,936,138 | 2022 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
HUM
HUMANA INC
|
Healthcare | 1.68% | — |
#18
Prev: #—
|
4.2 |
—
|
114,500 | — |
NEW
|
114,500 | $45,481,690 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
TMO
THERMO FISHER S...
|
Healthcare | 1.66% | 1.52% |
#19
4
Prev: #23
|
1.2 |
—
|
-3,520 | -3.8% |
P
S
|
89,395 | $44,819,077 | 2023 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
KYMR
KYMERA THERAPEU...
|
Healthcare | 1.60% | 0.94% |
#20
20
Prev: #40
|
2.6 |
—
|
40,604 | 12.0% |
P
S
|
378,163 | $43,363,951 | 2025 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
RYTM
RHYTHM PHARMACE...
|
Healthcare | 1.57% | 0.90% |
#21
22
Prev: #43
|
3.1 |
—
|
70,500 | 22.7% |
P
S
|
381,128 | $42,316,642 | 2023 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
GLTO
DAMORA THERAPEU...
|
Healthcare | 1.56% | 0.77% |
#22
30
Prev: #52
|
3.6 |
—
|
725,531 | 81.1% |
P
S
|
1,620,377 | $42,146,006 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ACAD
ACADIA PHARMACE...
|
Healthcare | 1.54% | 1.84% |
#23
5
Prev: #18
|
0.6 |
—
|
-824,800 | -33.4% |
P
S
|
1,646,399 | $41,653,895 | 2022 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
BTSG
BRIGHTSPRING HE...
|
Healthcare | 1.54% | 1.44% |
#24
2
Prev: #26
|
0.6 |
—
|
-419,809 | -41.3% |
P
S
|
596,753 | $41,617,554 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
TMDX
TRANSMEDICS GRO...
|
Healthcare | 1.50% | 1.09% |
#25
10
Prev: #35
|
3.6 |
—
|
280,324 | 85.1% |
P
S
|
609,715 | $40,497,270 | 2022 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
MBX
MBX BIOSCIENCES...
|
Healthcare | 1.45% | 1.49% |
#26
1
Prev: #25
|
0.6 |
—
|
-781,587 | -52.4% |
P
S
|
710,880 | $39,240,576 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
CLYM
CLIMB BIO INC
|
Healthcare | 1.35% | 0.35% |
#27
45
Prev: #72
|
3.5 |
—
|
1,267,700 | 82.9% |
P
S
|
2,797,375 | $36,477,770 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
CDNA
CAREDX INC
|
Healthcare | 1.29% | 1.26% |
#28
3
Prev: #31
|
0.5 |
—
|
-952,544 | -43.8% |
P
S
|
1,220,602 | $34,787,157 | 2025 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
MAZE
MAZE THERAPEUTI...
|
Healthcare | 1.26% | — |
#29
Prev: #—
|
4.0 |
—
|
1,140,040 | — |
NEW
|
1,140,040 | $34,018,794 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
DRUG
BRIGHT MINDS BI...
|
Healthcare | 1.26% | 1.31% |
#30
Prev: #30
|
1.0 |
—
|
-55,886 | -10.4% |
P
S
|
483,822 | $33,964,304 | 2025 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ACHC
ACADIA HEALTHCA...
|
Healthcare | 1.25% | 0.50% |
#31
31
Prev: #62
|
3.5 |
—
|
495,577 | 76.7% |
P
S
|
1,141,477 | $33,707,816 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
NKTR
NEKTAR THERAPEU...
|
Healthcare | 1.22% | 0.53% |
#32
29
Prev: #61
|
3.5 |
—
|
250,916 | 112.7% |
P
S
|
473,617 | $33,063,203 | 2022 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
CRVS
CORVUS PHARMACE...
|
Healthcare | 1.18% | 0.86% |
#33
15
Prev: #48
|
3.0 |
—
|
373,500 | 21.3% |
P
S
|
2,126,298 | $31,766,892 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
NRIX
NURIX THERAPEUT...
|
Healthcare | 1.15% | 0.91% |
#34
8
Prev: #42
|
0.5 |
—
|
-463,997 | -26.5% |
P
S
|
1,286,769 | $31,217,016 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
INSP
INSPIRE MED SYS...
|
Healthcare | 1.12% | 1.17% |
#35
2
Prev: #33
|
1.4 |
—
|
no change | no change |
P
S
|
677,570 | $30,226,398 | 2023 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
AVTX
AVALO THERAPEUT...
|
Healthcare | 1.11% | — |
#36
Prev: #—
|
3.9 |
—
|
1,629,182 | — |
NEW
|
1,629,182 | $30,107,283 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
N/A
ALAMAR BIOSCIEN...
|
|
Unknown | 1.09% | — |
#37
Prev: #—
|
3.9 |
—
|
1,083,983 | — |
NEW
|
1,083,983 | $29,365,099 | — | 13F Filing | 2026-06-30 | 2026-08-14 | ||
|
DHR
DANAHER CORP DE...
|
Healthcare | 1.06% | 0.88% |
#38
6
Prev: #44
|
2.4 |
—
|
11,300 | 8.1% |
P
S
|
150,627 | $28,691,431 | 2023 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ISRG
INTUITIVE SURGI...
|
Healthcare | 1.03% | 1.19% |
#39
7
Prev: #32
|
0.9 |
—
|
-7,160 | -9.3% |
P
S
|
70,137 | $27,892,082 | 2022 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ORKA
ORUKA THERAPEUT...
|
Healthcare | 0.98% | — |
#40
Prev: #—
|
3.9 |
—
|
278,164 | — |
NEW
|
278,164 | $26,472,868 | 2024 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
N/A
AVALYN PHARMACE...
|
|
Unknown | 0.98% | — |
#41
Prev: #—
|
3.9 |
—
|
801,395 | — |
NEW
|
801,395 | $26,381,923 | — | 13F Filing | 2026-06-30 | 2026-08-14 | ||
|
AVAH
AVEANNA HEALTHC...
|
Healthcare | 0.97% | 0.47% |
#42
22
Prev: #64
|
2.9 |
—
|
861,600 | 39.1% |
P
S
|
3,065,106 | $26,267,958 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
BIOA
BIOAGE LABS INC
|
Healthcare | 0.94% | 0.70% |
#43
12
Prev: #55
|
0.9 |
—
|
-167,458 | -13.9% |
P
S
|
1,033,129 | $25,321,992 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
BSX
BOSTON SCIENTIF...
|
Healthcare | 0.93% | 0.73% |
#44
9
Prev: #53
|
3.4 |
—
|
241,100 | 69.6% |
P
S
|
587,567 | $25,077,360 | 2023 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
VERA
VERA THERAPEUTI...
|
Healthcare | 0.90% | 0.70% |
#45
9
Prev: #54
|
2.4 |
—
|
40,900 | 7.8% |
P
S
|
564,724 | $24,232,307 | 2025 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
RGEN
REPLIGEN CORP
|
Healthcare | 0.89% | 0.19% |
#46
35
Prev: #81
|
3.4 |
—
|
129,600 | 272.8% |
P
S
|
177,100 | $24,163,524 | 2023 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ZURA
ZURA BIO LTD
|
Healthcare | 0.87% | 0.79% |
#47
3
Prev: #50
|
0.8 |
—
|
-8,694 | -0.2% |
P
S
|
3,980,295 | $23,483,741 | 2024 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
GH
GUARDANT HEALTH...
|
Healthcare | 0.82% | 1.54% |
#48
26
Prev: #22
|
0.3 |
—
|
-351,862 | -70.4% |
P
S
|
147,850 | $22,181,936 | 2023 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
EOLS
EVOLUS INC
|
Healthcare | 0.81% | 0.43% |
#49
19
Prev: #68
|
0.8 |
—
|
50,000 | 1.6% |
P
S
|
3,155,209 | $21,897,150 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
NTRA
NATERA INC
|
Healthcare | 0.80% | 0.86% |
#50
3
Prev: #47
|
0.3 |
—
|
-49,500 | -38.4% |
P
S
|
79,500 | $21,580,275 | 2022 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 |
Showing 1-50 of 112 holdings